Humans seem to produce arsenobetaine and dimethylarsinate after a bolus dose of seafood by Molin, Marianne et al.
1 
 
Humans seem to produce arsenobetaine and dimethylarsinate after a 1 
bolus dose of seafood  2 
 3 
M. Molina∗, S.M. Ulvena , L. Dahlb, V.H. Telle-Hansena, M. Holcka, G. Skjegstada, O. 4 
Ledsaaka, J.J. Slothb+c, W Goesslerd, A. Oshauga, J. Alexandere, D. Fliegelb, T.A. Ydersbondf 5 
and H.M. Meltzere 6 
 7 
a Department of  Health, Nutrition and Management, Faculty of Health Sciences, Oslo and 8 
Akershus University College of Applied Sciences, Postbox 4, St. Olavs Plass, NO-0130 Oslo, 9 
Norway.  10 
b National Institute of Nutrition and Seafood Research , PO Box 2029 Nordnes, N-5817 11 
Bergen, Norway. 12 
c National Food Institute, Technical University of Denmark, DK-2860 Søborg, Denmark. 13 
d Institute for Chemistry-Analytical Chemistry, Universitätsplatz 1, 8010 Graz, AUSTRIA. 14 
e Norwegian Institute of Public Health, PO Box 4404 Nydalen, N-0403 Oslo, Norway. 15 
f Statistics Norway, P.Box 8131 Dep, N-0033 Oslo, Norway. 16 
 17 
∗ Corresponding author: Marianne Molin, Department of  Health, Nutrition and Management, 18 
Faculty of Health Sciences, Oslo and Akershus University College of Applied Sciences, 19 
Postbox 4, St. Olavs Plass, NO-0130 Oslo, Norway. Telephone: +47 930 90 250, Fax: +47 64 20 
84 90 02, E-mail: Marianne.Molin@hioa.no. 21 
   22 
Running title: Differential response to arsenic in seafood. 23 
                                                 
Abbreviations: AB, Arsenobetaine ((CH
3
)
3
As+CH
2
COO−); AC, Arsenocholine  ((CH
3
)
3
As+CH
2
CH
2
OH); As (III), Inorganic 
arsenite (As(O−)
3
); As (V), Inorganic arsenate (O=As(O−)
3
); As, Arsenic; CRM, Certified Reference Material;  DMA, Dimethylarsinate 
((CH
3
)
2
AsO(O−));  HPLC, High Performance Liquid Chromatography; iAs, Inorganic arsenic; ICPMS, Inductively Coupled Plasma Mass 
Spectrometry; LOQ, Limit of Quantification; MA, Methylarsonate (CH
3
AsO(O−)
2
);  tAs, Total arsenic; TETRA, Tetramethylarsonium ion 
((CH
3
)
4
As+); TMAO, Trimethylarsine oxide ((CH
3
)
3
AsO); TMAP, Trimethylarsoniopropionate ((CH
3
)
3
As+CH
2
CH
2
COO−). 
 
2 
 
Abstract  24 
Seafood is the predominant food source of several organoarsenic compounds. Some seafood 25 
species, like crustaceans and seaweed, also contain inorganic arsenic (iAs), a well-known 26 
toxicant. It is unclear whether human biotransformation of ingested organoarsenicals from 27 
seafood result in formation of arsenicals of health concern. The present controlled dietary 28 
study examined the urinary excretion of arsenic compounds (total arsenic (tAs), iAs, AB 29 
(arsenobetaine), dimethylarsinate (DMA) and methylarsonate (MA)) following ingestion of a 30 
single test meal of  seafood (cod, 780 µg tAs , farmed salmon, 290 µg tAs or blue mussel, 690 31 
µg tAs or potato (control, 110 µg tAs) in 38 volunteers. The amount of ingested tAs excreted 32 
via the urine within 0-72h varied significantly among the groups: Cod, 74 % (52-92 %), 33 
salmon 56 % (46-82 %), blue mussel 49 % (37-78 %), control 45 % (30-60 %). The estimated 34 
total urinary excretion of AB was higher than the amount of ingested AB in the blue mussel 35 
group (112 %) and also ingestion of cod seemed to result in more AB, indicating possible 36 
endogenous formation of AB from other organoarsenicals. Excretion of iAs was lower than 37 
ingested (13-22 % of the ingested iAs was excreted in the different groups). Although the 38 
ingested amount of iAs + DMA + MA was low for all seafood groups (1.2-4.5 % of tAs 39 
ingested), the urinary DMA excretion was high in the blue mussel and salmon groups, 40 
counting for 25 % and 11 % of the excreted tAs respectively. In conclusion our data indicate a 41 
possible formation of AB as a result of biotransformation of other organic arsenicals. The 42 
considerable amount of DMA excreted is probably not only due to methylation of ingested 43 
iAs, but due to biotransformation of organoarsenicals making it an inappropriate biomarker of 44 
iAs exposure in populations with a high seafood intake. 45 
  46 
Key words: Arsenic, dimethylarsinate, seafood arsenic, arsenobetaine, dietary intervention. 47 
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1. Introduction  73 
Dietary arsenic (As), in particular from drinking water, has for some time been considered a 74 
major food safety issue (JECFA 2010). Several studies have identified seafood as the 75 
predominant food source of As, with rice, mushrooms and poultry as additional sources, 76 
depending on growing and feeding conditions (Borak and Hosgood, 2007; Dabeka et al., 77 
1993; EFSA, 2009; Munoz et al., 2005; Schoof et al., 1999; Tao and Bolger, 1999). In areas 78 
with low or no inorganic arsenic (iAs) exposure from drinking water, the variation  in total As 79 
(tAs) from food is mainly due to variations in seafood and rice consumption (e.g. 28 µg per 80 
day for an adult American woman and 160–280 µg per day for an adult Japanese woman) 81 
(Tao and Bolger, 1999; Tsuda et al., 1995; Uneyama et al., 2007).  82 
 83 
The toxicity of As is highly dependent on the chemical form and oxidation state, i.e. trivalent 84 
or pentavalent. The most potent toxicological potent arsenic compounds are the trivalent 85 
arsenic species, which easily generate reactive oxygen and reacts with sulfuric compounds 86 
(Fowler et al., 2007; Hughes, 2011; Styblo et al., 2002). In mammals, arsenic 87 
biotransformation occurs in alternating steps involving reduction and subsequent oxidative 88 
methylation to less toxic methylated forms such as methylarsonate (MA) and dimethylarsinate 89 
(DMA). In this process intermediate trivalent methylarsonous acid and dimethylarsinous acid 90 
are formed, which are equally more toxic than the corresponding pentavalent forms (EFSA, 91 
2009; Hughes, 2011; Styblo et al., 2002; Thomas et al., 2001; WHO, 2001). The dominating 92 
organic arsenicals in most seafood species, arsenobetaine (AB) is, despite limited evidence, 93 
considered harmless (Borak and Hosgood, 2007; Lai et al., 2004). Arsenosugars, the 94 
predominant form in algae and seaweed, have showed cytotoxic effects. The trivalent form of 95 
the arsenosugar is more toxic than the pentavalent counterpart, thus both forms are 96 
significantly less toxic than arsenate, MA (III) and DMA (III) (Andrewes et al., 2004; Sakurai 97 
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et al., 1997). No toxicological studies have  addressed  arsenolipids, lipid-soluble forms 98 
reported present in the fatty tissues of fish, and the human toxicology of these compounds 99 
remain unknown (Francesconi, 2010). 100 
 101 
In seafood both the total content of arsenic and presence of different chemical forms of 102 
arsenicals vary greatly with marine species, trophic level, diet/environment and ability of the 103 
species to metabolize arsenicals. In Atlantic cod, the total As (tAs) concentration range from 104 
0.4-52.4 mg As/kg wet weight (Julshamn et al., 2004; National Institute of Nutrition and 105 
Seafood Research, 2011). However, the amount of iAs in fish fillets of cod has been reported 106 
to be less than 0.001 µg/kg wet weight (Sloth et al., 2005). In fillets of farmed Atlantic 107 
salmon, the tAs concentration range from 0.6-4.8 mg As/kg wet weight (Julshamn et al., 108 
2004; National Institute of Nutrition and Seafood Research, 2011), and iAs is found only in 109 
trace amounts (Sloth et al., 2005). AB is the predominant form of As both in cod and salmon 110 
fillets (Dahl et al., 2010).  111 
 112 
Arsenolipids have recently been identified in tuna fish and cod liver (Taleshi et al., 2010), and 113 
because of its high fat content, salmon fillet is likely to contain arsenolipids as well. In blue 114 
mussels from Norwegian fjords, the tAs concentration ranged from 1.2-13.8 mg As/kg wet 115 
weight (Sloth and Julshamn, 2008). In addition to relatively high levels of AB, DMA and 116 
arsenosugars, blue mussels may contain  high concentrations of iAs, up to 5.8 mg As/kg wet 117 
weight (Sloth and Julshamn, 2008).  118 
 119 
In general, bioavailability and kinetics of arsenic compounds will vary with their 120 
physiochemical properties (EFSA, 2009), environmental factors, their dose, as well as 121 
differences among humans in methylation capacity and handling of arsenosugars (Tseng, 122 
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2009). Irrespective of food source, iAs is generally considered to be absorbed rapidly and 123 
almost completely after ingestion, although solubility and matrix also may play a role (EFSA, 124 
2009). In spite of the fact that the metabolic pathway of iAs has not yet being fully clarified, 125 
there has been a general consensus that a large part will undergo methylation and end up 126 
being excreted as DMA (Cui et al., 2008; Hayakawa et al., 2005; Tseng, 2009). MA and 127 
DMA present in foods seem to be excreted in the urine largely in their unchanged forms and 128 
only a minor proportion of MA is converted to DMA (Tseng, 2009). A possible further 129 
metabolism of DMA has been observed as a urinary metabolite in Bangladeshi women in the 130 
form of thio-DMA (Raml et al., 2007), and further metabolism of DMA to TMAO was 131 
observed in one human subject who ingested a high dose of DMA (Marafante et al., 1987). 132 
 133 
Many details about absorption and metabolism of As compounds in humans are still 134 
unknown, in particular about organoarsenicals from seafood (Borak and Hosgood, 2007). 135 
Several studies have noted that seafood intake increases the urinary excretion of DMA, the 136 
main metabolite from iAs metabolism (Buchet et al., 1996; Heinrich-Ramm et al., 2002; Lai 137 
et al., 2004; Mohri et al., 1990). Arsenosugars and arsenolipids are probable sources of the 138 
increase in the urinary excretion of DMA, as earlier interventions in humans have identified 139 
an increased urinary excretion of DMA after intake of these arsenicals (Francesconi et al., 140 
2002; Ma and Le, 1998; Schmeisser et al., 2006). The large amounts of AB found in seafood 141 
have for years been considered to be readily absorbed and then rapidly excreted unchanged in 142 
urine (Lai et al., 2004). This notion is largely based on one study using isotopically labeled 143 
AB, showing rapid excretion and with less than1 % of the radioactivity remaining in the body 144 
24 days after ingestion (Brown et al., 1990). Notable, hardly any quantitative data exist on the 145 
absorption of AB in humans (EFSA, 2009). 146 
 147 
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The aim of the present study was to examine the urinary As excretion following exposure to 148 
various As compounds from different types of seafood given as a bolus dose. The study 149 
design made it possible to investigate several basic assumptions often made about As 150 
metabolism: 1. Absorption of AB is rapid and more or less complete. 2. Absorbed AB is 151 
excreted rapidly, completely and unchanged, mainly in urine, and the process is basically 152 
independent on the dietary source of AB. 3. There is no formation of AB in the body. 4. DMA 153 
(and MA) is mainly produced by methylation of iAs, and urinary DMA (or MA) can therefore 154 
be used as a marker of iAs load. Finally, the design of our study made it possible to explore 155 
whether seafood consumption can increase the body load of iAs derived from 156 
organoarsenicals.  157 
 158 
2. Subjects and methods 159 
2.1. Subjects 160 
Study participants were students at Akershus University College, Norway, and the 161 
intervention took place in March 2006. Of 48 potential subjects assessed for eligibility, 38 162 
healthy volunteers (28 women and 10 men) aged 20–40 years were compliant with the 163 
protocol throughout the study. Smokers, pregnant or lactating women, persons habitually 164 
consuming seafood more often than three times a week (i.e. a higher seafood intake than 165 
generally recommended in Norway), and persons using medical drugs other than 166 
contraceptives were excluded. The study was approved by the National Committee for 167 
Research Ethics and was carried out in accordance with The Code of Ethics of the World 168 
Medical Association. Written informed consent was obtained from each participant. 169 
 170 
 171 
 172 
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2.2. Study design  173 
The study period lasted 10 days in total (Figure 1). During a one week washout period (day -7 174 
until day 0) and throughout the study period, the subjects were asked to abstain from eating 175 
seafood, mushrooms, rice or rice products and dietary supplements. The consumption of cod 176 
liver oil, a food supplement commonly used in Norway, was discouraged, starting four weeks 177 
prior to day 0 and lasted throughout the study period. Four randomized treatment groups 178 
received a test meal at the University College on day 0. The meal consisted of 150 g of either 179 
cod (Gadus morhua) (n=9), farmed salmon (Salmo salar) (n=11), blue mussel (Mytilus 180 
edulis) (n=8) or potato (n=10) served for breakfast (8-10 am). Following intake of the four 181 
different test meals, all subjects consumed a strictly controlled diet prepared and served at the 182 
University College the following 72 hours (day 0-2). The supper was brought in bags and 183 
eaten in the subject’s homes. The participants were requested to eat all of the food served and 184 
to maintain their normal physical activity routines. 185 
 186 
2.3. Intervention diet 187 
The blue mussels were purchased from Safjord shellfish (Varaneset, Norway), and examined 188 
for algal toxins by the Norwegian Food Safety Authority. The cod was bought from Ural Nor 189 
Fish AS (Moldtustranda, Norway), and the salmon from Coast Seafood AS (Måløy, Norway). 190 
The cod and the salmon were already cleaned and filleted when purchased. To ensure 191 
homogenous distribution of As in the test meals, homogenous mixtures of the filleted fish 192 
were made into puddings, which were stored at -20 ºC until meal preparation. The blue 193 
mussels were steamed for 10 minutes, removed from their shells, frozen separately and 194 
immediately stored at -20 ºC until meal preparation. The test meals for all four intervention 195 
groups consisted of pies, using an identical recipe except for the 150 g of seafood/potato. The 196 
strictly controlled diet was designed to be low in As from other foodstuffs and in accordance 197 
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with the Nordic recommended daily intake of energy (2100 kcal/8.8 MJ). Those who needed 198 
more energy were provided with “energy buns” without any restriction. Additionally, tap 199 
water (the tAs level in Norwegian groundwater is mostly below 0.2 μg As/L (Olsen and 200 
Morland, 2004)) was provided with no restriction. Samples of the test pies and other meals 201 
were homogenized and stored at -20 ºC for subsequent As determination.  202 
 203 
2.4. Blood sampling 204 
Blood samples were collected from fasting subjects (minimum12 h) at the same time (8-10 205 
am) on day 0. In addition blood samples were collected 2h, 4h, 24h and 48h after ingestion of 206 
the test meal. Plasma was obtained from EDTA tubes kept at room temperature (0-30 min) 207 
and centrifuged at 1300x g for 10 min. All plasma samples were kept frozen (-70 ºC) until 208 
analysis. 209 
 210 
2.5. Urine samples  211 
Following ingestion of the test meals, urine was collected in three periods during the first 24 212 
hours: (0.1) between the test meal and 2 pm (approximately 0-5h after the test meal); (0.2) 2-7 213 
pm (approximately 5-10h after the test meal); and (0.3) 7 pm until first urination on the 214 
following day (approximately 10-24h after the test meal) (Figure 1). For the next 48 hours, 215 
24-hour urine batches were collected. Morning spot samples of urine were collected at 216 
baseline (day -7), and before ingestion of the test meal (0 h). All urine samples were kept at 4 217 
oC until all urine from each day/period was pooled. The total volume was then measured, and 218 
15 ml of the urine was distributed into aliquots and stored below –70 oC until analysis.  219 
 220 
 221 
 222 
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2.6. Analytical methods 223 
The tAs in the food (test meals and 72-hour controlled diet), plasma and the urine were 224 
determined using Inductively Coupled Plasma Mass Spectrometry (ICPMS) as previously 225 
described (Julshamn et al., 2007; Sloth et al., 2005). The As speciation analysis of the food 226 
was performed using HPLC-ICPMS (Sloth et al., 2003; Sloth et al., 2005). 227 
 228 
The accuracy of the tAs determination for foodstuffs was evaluated by means of analysis of 229 
two certified reference materials (CRM): DORM-2 Dogfish muscle (20.1 ± 1.0 mg/kg) 230 
(National Research Council of Canada (NRCC)); and BCR CRM627 Tuna fish tissue (5.1 ± 231 
0.3 mg/kg) (IRMM, Geel, Belgium). The obtained results agreed well with the respective 232 
certified values of 18.0 ± 1.1 mg/kg and 4.8 ± 0.3 mg/kg, respectively. The same BCR CRM 233 
627 Tuna fish tissue was used for evaluation of the speciation analysis of the food samples. 234 
The results were also compared with the results given in Sloth et al. (2003) for, TMAO 235 
(trimethylarsine oxide), AC (arsenocholine), TETRA (tetramethylarsonium ion) and TMAP 236 
(trimethylarsoniopropionate), as the CRM is only certified for AB and DMA (Maier EA, 237 
1997). The obtained results (AB: 3.7 mg/kg, DMA: 0.15 mg/kg, TMAO: 0.016 mg/kg, AC: 238 
0.016 mg/kg, TETRA: 0.034 mg/kg, and TMAP: 0.029 mg/kg), agreed well with the certified 239 
values (AB: 3.9 ± 0.2 mg/kg; DMA: 0.15 ± 0.01 mg/kg) and the results given in Sloth et al. 240 
(2003) (TMAO: 0.010±0.002 mg/kg, AC: 0.012±0.002 mg/kg, TETRA: 0.037±0.002 mg/kg, 241 
and TMAP: 0.033±0.002 mg/kg). NIES No 18 Human urine (National Institute for 242 
Environmental Studies, Ibaraki, Japan), is a CRM for tAs, AB and DMA, and was used to 243 
evaluate the tAs of human urine samples. The obtained results (tAs 150 ± 6 µg/L and DMA 244 
42 ± 6 µg/L), agreed well with the CRM (tAs 137 ± 11 µg/L and DMA 36 ± 9 µg/L).  245 
 246 
 247 
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2.7. Determination of arsenobetaine, DMA, MA and iAs in urine 248 
Prior to the measurements the samples were filtrated (0.2 µm) and subsequently injected 249 
undiluted into the HPLC system. AB was measured with cation- exchange chromatography 250 
on a Zorbax 300 SCX (4.6 x 250 mm) column. A 10 mM aqueous pyridine solution at pH 2.3 251 
and a flow rate of 1.0 mLmin-1 was used as mobile phase. The injection volume was 5 µL and 252 
the column temperature was 30°C. DMA, MA and iAs was measured with anion-exchange 253 
chromatography on a PRP-X100 (4.6 x 150 mm) with 20 mM NH4H2PO4 solution at pH 6.0 254 
used as a mobile phase. The injection volume was 10 µL and the column temperature was 255 
40°C. For quality assurance the NIES CRM No 18 human urine was used as reference 256 
material. AB, measured: 67.5 ± 1.8 µg As / L; certified: 69 ± 12 µg / L. DMA, measured: 42 257 
± 2 µg As/L; certified: 36 ± 9 µg/L.  Limit of quantification were taken as the concentration 258 
of the lowest standard: 0.5 µgL-1. 259 
  260 
Non-quantified values (i.e. values below LOQ), were set at LOQ/2 (Kroes et al., 2002). The 261 
following values (LOQ/2) were used in the present study: iAs (0.15 µg/kg); DMA (0.25 262 
µg/kg); and MA (0.15 µg/kg). 263 
 264 
2.8. Estimation of total As absorption  265 
In a one-compartment model (Beckett WS, 2007) the daily amount of total As excreted in 266 
urine after a single dose of seafood arsenical can be approximated by a geometric progression 267 
with a constant ratio k between successive terms, An+1 = kAn. Therefore we estimated the total 268 
remaining excretion of As, i.e. the amount remaining in the body after the last urine collection 269 
on day 2, by the tail sum of a geometric series, which is k/(1-k) times the excretion the last 270 
day measured. For example, with k = 0.5, the sum of the remaining days will be equal to the 271 
excretion the last days measured. With a low baseline excretion and the three days' amount 272 
Feltkode endret
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excreted measured as A0, A1 and A2, the total excretion of the dose of arsenical can hence be 273 
(crudely) estimated as A0+A1+A2 + A2k/(1-k) = A0+A1+A2/(1-k). Since As, irrespective of 274 
species, is considered to be mainly excreted in urine, the total excreted amount in urine can be 275 
used as a crude estimate of the absorption of a single dose As ingested after an initial wash-276 
out period, as was the case here. The ratio k was estimated as the average day2/day1 excretion 277 
ratio for the participants in the three seafood-consuming groups. The k-value was then applied 278 
to individual excretion records, to produce individual estimates of total As excretion. 279 
 280 
Assuming that 1) only a small amount of As is excreted by other routes (EFSA, 2009) and 2) 281 
there is no accumulation of As after the bolus dose, the excretion estimate may be used as a 282 
(conservative) estimate of As absorption. Linear regression of logarithms of daily urinary tAs 283 
excretion day 2 vs day 1 and day 1 vs day 0 was performed to check how much tAs excretion 284 
deviated from this basic, simple model where the excreted daily amount is a fixed fraction of 285 
total circulating As. If the observed slope of the logarithmic linear relationship does not 286 
approach 1, which the exponential model implies, there is systematic deviation from the 287 
model. Then there would be a concentration-dependent elimination rate with the simplest 288 
form of the basic relation being, An+1 = k AnC. Furthermore, if the observed regression slopes 289 
of the log-transformed excretion data are different for different pairs of consecutive days, 290 
there may in addition be a time-dependent elimination rate.  291 
 292 
2.9. Statistical analyses 293 
The SPSS 14.0 software package (SPSS Inc., Chicago, IL; USA) and R 2.10.1 (http://cran.r-294 
project.org/) were used for the statistical analyses. The non-parametric test Mann Whitney, 295 
ANCOVA and t-tests with Holm's correction for multiple comparisons were used to identify 296 
any significant differences in the urinary As excretion between the seafood intervention 297 
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groups and the control group. In particular, ANCOVA models were applied to assess possible 298 
group wise differences in AB and DMA excretion relative to AB and non-AB As absorption, 299 
respectively (Table 4). In all tests, p-values < 0.05 were considered significant. 300 
 301 
3. Results  302 
3.1. Baseline characteristics and urinary tAs concentrations 303 
The baseline characteristics and urinary tAs concentrations of the study subjects are shown in 304 
Table 1. The mean urinary concentration of tAs a week before the test meal (day -7) was 83 305 
μg/L. After the 7 day wash-out period, at the start of intervention period (day 0), the mean 306 
urinary concentrations were below 30 μg/L (average 20 μg/L) in all four groups. This is 307 
similar to the concentrations of urinary tAs reported in non-exposed individuals (Fowler et al., 308 
2007).   309 
 310 
3.2. As content of the diet 311 
The tAs contents of the test meals of cod and blue mussel were about three times higher than 312 
the tAs content of the salmon test-meal (Table 2). The tAs content of the control test-meal 313 
without seafood was low (Table 2). In the cod and salmon groups, unidentified arsenicals 314 
accounted for approximately 16–25 % of tAs while the blue mussel diet consisted of 60 % 315 
unidentified As compounds. The tAs intake during the 72 h controlled diet (no seafood) 316 
consumed by all groups following the test meal was 110 µg (Table 2). 317 
 318 
3.3. Measured tAs excretion and crude estimates of total tAs excretion 319 
The initial 24 h total As excretion varied markedly between the groups (Table 3). In the cod 320 
group, 77 % of the urinary tAs excreted day 0-2 was excreted during the first 24 h after intake 321 
of the test meal (446 of 576 µg tAs, mostly AB). This was five times higher than the excretion 322 
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during the next 24h. The excretion rate was much slower initially in the two other seafood 323 
groups (Figure 2A), and it also declined less rapidly. In the three seafood-consuming groups, 324 
tAs excretion was about twice as high on day 1 compared to day 2. 325 
 326 
The average day2/day1 excretion ratio for tAs in these groups was k= 0.54 ± 0.20. This ratio 327 
did not differ significantly among the groups. The observed slope of the logarithmic linear 328 
relationship of day 2 vs day 1 urinary excretion was 0.86, and the corresponding slope for day 329 
1 vs day 0 was 0.48. In a simple kinetic model the slope would be 1, thus our results indicate 330 
both concentration and time dependency in the tAs excretion. Consequently, the tAs half-life 331 
increased with decreasing body burden - in the cod group it was initially <16h. With a daily 332 
tAs excretion of 50-100 μg, half-life seemed to be around 24h. The time course of urinary 333 
excretion and plasma concentrations of tAs is illustrated by Figure 2 A-C. The plasma tAs and 334 
urinary tAs concentrations peaked after 2h and 10h after ingestion of the test meal, however 335 
the excretion pattern was similar for both urine and plasma (Figure 2 A-B).  336 
 337 
Further analyses indicated that, rather than following a biphasic pattern typical of two-338 
compartment models, the As excretion changed more continuously, indicating a more 339 
complex excretion and retention situation. The data do, however, not allow for a more 340 
detailed modelling. We found that, in spite of the changing half-life for tAs excretion, treating 341 
the tAs excretion after the test meal as a geometric series would still give a good 342 
approximation of total excretion. Using the mean of the day2/day1 excretion ratios, 0.54, as 343 
the constant k, total tAs excretion after day 2 could thus be crudely estimated as 0.54/(1-344 
0.54)=1.17 times the day 2 excretion (Table 3).  345 
 346 
 347 
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3.4. Estimates of absorption based on total As excretion 348 
The observed day 0-2 and estimated tAs species excretion, with corresponding percentages of 349 
ingested amounts, are shown in Table 3, columns 6-9. Using estimated excreted tAs as an 350 
estimate of absorption, the tAs absorption was estimated to be 81 % in the cod group, which 351 
was significantly different (p<0.015) from the salmon group, 64 % and the blue mussel group, 352 
56 %. The difference in tAs absorption between the salmon and blue mussel groups was not 353 
statistically significant. Considerable inter- individual differences were observed in all groups, 354 
with ranges 58-99 %, 49-93 % and 41-86 % in the cod, salmon and blue mussel groups, 355 
respectively (Table 3, column 9). 356 
 357 
The data indicated larger inter-individual than inter-species absorption differences between 358 
As species, consequently, each subject's tAs absorption estimate was used for all As species.  359 
Such inter-individual differences are illustrated by the individual cumulative tAs excretion 360 
curves (Figure 2D). Although absorption in the cod group was significantly higher than in the 361 
salmon group, there was some overlap. In these groups, there were larger inter-individual 362 
variations during the first hours than during the last.  363 
 364 
3.5. Arsenobetaine (AB) 365 
AB was the major As compound identified in the seafood investigated in this study, 366 
comprising 73 %, 76 %, 33 % of the tAs ingested in the cod, salmon and blue mussel groups, 367 
respectively (Table 3, column 2). The average urinary AB excretion rates during the first 72 368 
hours showed a very pronounced peak of AB excretion around 10h in the cod group, but 369 
smaller group-wise differences thereafter (Figure 3A). A considerable variation in the 370 
individual relative cumulative excretion patterns in the cod and salmon groups appeared, with 371 
a slower initial AB excretion in all subjects in the salmon group, but also a lower rate of 372 
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excretion relative to ingested amount of AB in that group (Figure 3B). More AB than the 373 
amount ingested was estimated excreted by most subjects in the blue mussel group (average 374 
112 %, Table 3, column 9). The average observed day 0-2 excretion of AB in the cod and 375 
blue mussels groups were 90 % and 99 % of the ingested amount respectively, while, the 376 
corresponding average apparent absorption percentages in these groups were 81 % and 56 %. 377 
When observed AB excretion day 0-2 was plotted as a percentage of estimated AB 378 
absorption, most subjects in the cod and blue mussels were therefore placed above 100 % 379 
(Figure 3C). The same relationship could be inferred from the result of the ANCOVA 380 
analysis (Table 4).  381 
 382 
Average estimated total AB excreted in the cod group was 556 µg (range 409-640, Table 3, 383 
column 8). In comparison, only about 139 µg (range 11-198) of ingested AB was excreted 384 
during the three day intervention period in the salmon group. The estimated apparent total As 385 
absorption was 64 % in the salmon group, and the average AB absorption therefore has an 386 
upper bound of 84 % (=0.64/0.76 x 100, assuming zero absorption of non-AB As) in this 387 
group. This would imply that much less AB is excreted than absorbed: On the average 75 %, 388 
139 vs 185 µg. A lower bound estimate is obtained assuming 100 % absorption of non-AB As 389 
(69 µg), then average AB absorption would be 53 % ((185-69)/219 x 100, Table 3, columns 1 390 
and 8). In this case, average AB excretion would be 120 % of absorption.   391 
 392 
Thus, most subjects in the cod and blue mussel groups, and possibly also some in the salmon 393 
group, seemingly excreted as much or even more AB than they absorbed, and several 394 
individuals even more than they ingested.  395 
 396 
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The test meal of the control group was void of fish or seafood components (Table 2). But 397 
since the controlled diet on day 1 contained some As, probably originating from the lunch 398 
meal consisting of roasted chicken, the control group ingested 110 µg tAs throughout the 3 399 
day intervention period. AB constituted 77 µg (70 %) of the tAs (Table 3), and 45 % of 400 
ingested tAs was excreted day 0-2. 401 
 402 
The differences between the groups in the handling of AB were quantified and analyzed by 403 
ANCOVA modelling of excreted AB vs estimated absorbed AB (Table 4). Modelling AB 404 
excretion with separate coefficients for AB for each group was significantly better than 405 
modelling with common coefficients (ANOVA test, data not shown). In the model, the 406 
intercept (43 µg per 72 h) can be interpreted as a common baseline AB excretion, i.e. about 14 407 
µg/day. The coefficients are estimates of group-wise excretion fractions (minus baseline 408 
excretion) relative to AB absorption in the study. Coefficients significantly above 1 thus 409 
indicate de novo AB formation in the body.  410 
 411 
The ANCOVA model for AB excretion covered most of the variation (R²=0.99). In the blue 412 
mussel group and cod group, about 1.6 µg and 1.1 µg AB was excreted for each µg AB 413 
absorbed, respectively. This would indicate additional formation of AB in the body following 414 
consumption of blue mussels and cod. Because of the relatively high baseline excretion, in 415 
spite of the low coefficient (0.68), the model does not indicate AB degradation in the salmon 416 
group. In the control group, the individual variability was higher, and there was no 417 
statistically significant association between average AB excretion and absorbed AB. 418 
  419 
 420 
 421 
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3.6. Dimethylarsinate (DMA) 422 
In all groups, the excretion of DMA was higher than the amount ingested. The blue mussel 423 
group excreted the highest amount of DMA. There was approximately a 2.5-fold increase in 424 
excreted vs. ingested amount of iAs+DMA+MA, mostly excreted (90 %) as DMA (Table 3). 425 
The amount of DMA excreted was about 4.5 times the ingested amount (71 vs. 16 µg). With 426 
only 15 µg iAs ingested, the excreted DMA is likely to be mostly originating from 427 
organoarsenicals. The DMA results and results on other urinary arsenicals in the blue mussel 428 
group will be discussed further in a separate publication. In the cod group, excreted amount of 429 
iAs+DMA+MA was about 1.5 times the ingested amount (13.2 vs 8.8 µg). The sum of these 430 
metabolites only accounted for about 2 % of the tAs excreted in the cod group, as compared 431 
to about 11 %, 25 % and 23 % in the salmon, blue mussel and control groups, respectively. In 432 
the control group, DMA excreted (8 µg) was 5 times the amount ingested, and the sum of 433 
iAs+DMA+MA excreted was about 1.3 times the amount ingested (i.e. 12.1 vs 9.2 µg) (Table 434 
3, column 6). 435 
 436 
The optimal ANCOVA model for excreted DMA vs estimated absorbed non-AB in Table 4 437 
(see explanation above), expressed urinary excretion of DMA 0-72h as a linear function of 438 
(estimated) absorbed non-AB As, with a common intercept and slopes specific for each group 439 
(R2=0.93). The slopes (coefficients) are approximations of group-wise excretion percentages 440 
relative to non-AB As intake in the study. The standard deviations of the coefficients obtained 441 
for DMA indicated considerable inter- individual variation within the cod, salmon and control 442 
groups. Using the ANCOVA model, about 52 % and 43 % of non-AB As seems to have been 443 
excreted as DMA in the salmon and blue mussel group respectively, as opposed to only about 444 
10 % in the cod group (for individual comparisons of the cod and salmon groups, see Figure 445 
4B). This indicates that there is a higher content of DMA precursor arsenic compounds, 446 
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possibly arsenosugars and/or arsenolipids in salmons and blue mussels, which can be 447 
converted into DMA in humans.  448 
 449 
The average total DMA urinary excretion rate in each group during the first 72 hours peaked 450 
between 12 and 18 hours (Figure 4A). The individual cumulative average DMA excretion 451 
curves relative to the non-AB fraction ingested (Figure 4B) for the salmon and cod groups 452 
clearly show both inter-individual variations, particularly in the salmon group, as well as 453 
group differences with a much lower relative excretion in the cod group. The cod group 454 
ingested about 200 µg unknown As species during day 0-2 (Table 2), but these species appear 455 
mostly not to be converted into DMA in the body. A differential pattern emerged for the four 456 
groups when the estimated total non-AB As absorbed was plotted against DMA excretion as a 457 
fraction of estimated amount non-AB absorbed (Figure 4C). In the salmon group, a large 458 
fraction was excreted as DMA, but with large individual variation. In the cod group, only a 459 
small fraction of absorbed non-AB As was excreted as DMA in all subjects. Because of large 460 
individual variation, there was no significant association between non-AB absorption and 461 
DMA excretion in the control group. 462 
 463 
3.7. Inorganic As (iAs) and MA 464 
The intake of iAs was generally low for all groups, but in absolute amounts, twice as high for 465 
the blue mussels group when compared with the other groups. The iAs ingested contributed 466 
0.8 %, 2.3 % and 2.2 % of total As ingested in the cod, salmon and blue mussel group 467 
respectively. The iAs content in the cod and salmon test meal was somewhat higher than 468 
earlier studies have reported, while the iAs content in the blue mussel meal was in accordance 469 
with earlier studies (Borak and Hosgood, 2007; Sloth and Julshamn, 2008; Sloth et al., 2005; 470 
Uneyama et al., 2007). The urinary excretion of iAs was low in all seafood groups, between 471 
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14-22 % of the ingested amount of iAs (Table 3). The MA content in the diet was below 472 
LOQ. Some previous human intervention studies have reported the presence of small amounts 473 
of MA in seafood (Buchet et al., 1994; Hsueh et al., 2002; Mohri et al., 1990), while others 474 
have not detected any MA (Heinrich-Ramm et al., 2002). All subjects in the seafood groups 475 
excreted small amounts of MA, accounting for 0.7 %, 2.3 %, and 2.2 % of the tAs compounds 476 
excreted in the cod, salmon and blue mussel group respectively (Table 3). 477 
 478 
4. Discussion 479 
The main finding of this study was the large apparent differences in the pattern of As species 480 
excreted following consumption of a single meal of different seafood. Another, and somewhat 481 
unexpected, finding was the high excretion of AB relative to intake, strongly indicating that 482 
some of the AB excreted is a result of biotransformation from other organic As species. More 483 
expected, but still striking, was the considerable amount of DMA formed, of which only a 484 
minor part can be explained by methylation of ingested iAs.  485 
 486 
The excretory pattern of tAs is consistent with findings from several other studies of As 487 
following seafood intake, where 50 %-86 % of the ingested tAs was excreted in urine within 488 
two days (Arbouine and Wilson, 1992; Buchet et al., 1996; Buchet et al., 1994; Le et al., 489 
1994; Tam et al., 1982). Also, in agreement with our findings, biological half-life of As 490 
ingested in seafood appears, initially, to be less than 20 hours  (Fowler et al., 2007). Also, the 491 
plasma data (Figure 2C) indicate rapid absorption and subsequent somewhat slower excretion, 492 
consistent with some degree of biotransformation. Together, the plasma and urine data 493 
indicate a strong association between absorption and excretion, retention playing a minor role 494 
quantitatively. 495 
  496 
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4.1. Origin and metabolic fate of arsenobetaine (AB) 497 
AB was the dominating dietary As species analyzed, accounting for 73 %, 76 %, 33 % and 70 498 
% of tAs in the cod, salmon, blue mussels and control groups, respectively. Constant AB 499 
absorption, regardless of source, would necessarily imply similar relative absorptions in the 500 
cod, salmon and control groups, possibly with a less efficient absorption at the highest AB 501 
doses (Arbouine and Wilson, 1992). Our results show the opposite: Not only did estimated 502 
overall individual absorption of tAs vary between 39 % and 99 % , but, in the groups with 503 
similar AB percentage of intake, average group-wise absorption increased with tAs ingested 504 
(mean: cod 81 %, salmon 64 %, control 58 %). In the subjects with highest absorption, 505 
urinary excretion must necessarily be the dominating excretion pathway, and when AB is the 506 
dominating species, tAs and AB absorption cannot possibly be too far apart from each other. 507 
If the lowest absorbing subjects in the cod and salmon groups had zero absorption of non-AB 508 
As, their estimated AB absorption could still not exceed 78 % (447/570) and 64 % (141/220). 509 
With 30 % of non-AB absorption, which seems more likely based on As species in urine, AB 510 
absorption would be 68 % and 55 % for these subjects. It should be noted that with low non-511 
AB absorption, in some cases the observed AB excretion cannot in many cases fully account 512 
for all AB absorbed. Therefore, based on our data, some biotransformation of AB to other 513 
arsenic species cannot be entirely ruled out. On the other hand, for the highest absorbers in the 514 
cod and salmon groups, estimated total As excretion was 769 and 267 µg, respectively. If 515 
these subjects had 100 % absorption of non-AB As, that would account for 210 and 69 µg, 516 
respectively. That would leave 559 (98 % of ingested AB) and 198 µg (91 % of ingested AB), 517 
respectively as lower bounds for absorbed AB in these subjects. Hence, our data indicate large 518 
variations in AB absorption, both individually and with food source; from almost 100 % and 519 
down to 60 % or lower. Furthermore, while not providing any conclusive evidence, they do 520 
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not rule out the possibility that the low AB apparent absorption in some individuals is in part 521 
due to AB being biotransformed. 522 
 523 
In this study, initial AB excretion, particularly in the cod group, was rapid and seemed 524 
somewhat faster than initial excretion of other As species. Our results are consistent with 525 
findings in earlier studies which indicate that As from seafood containing mostly AB, like 526 
cod, is eliminated faster than As from seafood containing a higher proportion of arsenosugars 527 
and arsenolipids, like blue mussels and salmon (Arbouine and Wilson, 1992; Le et al., 1994). 528 
This knowledge and our observation that particularly the blue mussel group excreted more 529 
AB than absorbed, strongly indicate formation of AB from other organic As species of 530 
seafood origin in humans.   531 
 532 
With apparent individual tAs absorption ranging from 58 % to 99 % (Table 3, column 9) in 533 
the cod group, the data indicate an absorption of about 125-200 μg non-AB arsenic in this 534 
group. Since only a fraction of non-AB arsenic could have been excreted as iAs+DMA+MA, 535 
and a significant amount of As is to be found in the unidentified fraction only on day 0. AB 536 
seems to be one likely candidate metabolite for excretion of the remaining non-AB arsenic 537 
ingested. With a mean estimated tAs absorption of 81 %, and similar AB absorption (see 538 
above), an average of about 450- 480 µg AB (could have been absorbed. This would account 539 
for approximately 80-85 % of the estimated total excretion of 556 µg AB (Table 3), hence, 540 
leaving about 15-20 % of the AB excreted by the cod group to be of non-AB origin. 541 
Similarly, a possibly larger fraction of urinary AB could be of non-AB arsenic in the blue 542 
mussel group.  543 
 544 
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The assumption that some of the excreted AB originates from the non-AB fraction of the cod 545 
is further supported by the ANCOVA model results (Table 4). In the cod group, a 546 
significantly lower proportion (10 %) of absorbed non-AB As was excreted as DMA in 547 
comparison with the fraction in the other groups. 548 
 549 
In the blue mussel group, the regression coefficient (Table 4) describing the relation between 550 
excreted and estimated absorbed AB was significantly higher than those of the other groups. 551 
There was little individual variation in the coefficient within the blue mussels group. Excreted 552 
amount of As day 0-2, expressed as a fraction of ingested varied twofold in this group (37-78 553 
%, Table 3), and taken together, these observations could indicate that the absorption of non-554 
AB arsenic and AB was similar in the blue mussel group.  555 
 556 
In a recent study it was found that 3 out of 5 volunteers consuming an AB-free diet, excreted 557 
AB in their urine. The authors speculated this could be due to either a long-term excretion of 558 
accumulated AB from the pre-trial diet or that AB is a human metabolite of DMA or iAs in 559 
the trial-food (Newcombe et al., 2010). Since our participants did not ingest any seafood 560 
seven days prior to the seafood test meal, and excreted very little As at the start of the study, it 561 
is not likely that accumulated lipid-soluble arsenicals contributed significantly to urinary 562 
excretion of AB. Most of the AB additional to that ingested and absorbed is probably a result 563 
of biotransformation of other arsenicals present in the test meals into AB.  564 
 565 
The suggested biotransfomation would explain most of the observations on the kinetics and 566 
metabolism of AB. At first sight, AB does indeed appear as a readily absorbed, metabolically 567 
inert and rapidly excreted As compound. At closer scrutiny, we get a somewhat more 568 
complex picture, with a possibility for biotransformation, accounting for a significant part of 569 
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As absorbed or excreted. Thus, AB excretion does not always reflect AB intake very well. 570 
Moreover, our data indicate that biotransformation of a small part of ingested AB cannot be 571 
entirely ruled out.  572 
 573 
4.2. DMA formation and excretion 574 
Consistent with previous human seafood consumption studies (Arbouine and Wilson, 1992; 575 
Buchet et al., 1996; Buchet et al., 1994; Heinrich-Ramm et al., 2002; Lai et al., 2004; Le et 576 
al., 1994; Mohri et al., 1990), DMA accounted for 8 % of the total tAs excreted in urine in the 577 
salmon group and 22 % in the blue mussels group, but only about 1 % cod group (Table 3). In 578 
two studies by Buchet and co-workers (Buchet et al., 1996; Buchet et al., 1994), the 579 
proportions of DMA relative to tAs excreted in urine after cod consumption were higher than 580 
in our study, 7 % and 12 %. In the same two studies, the proportions of DMA excreted after 581 
intake of mussels were 33 % and 42 %, which are comparable to our results. 582 
  583 
Mohri et al. (1990) observed high amounts of trimethylarsenic compounds (probably mainly 584 
AB), in urine on the day after the participants ate dinners consisting mainly of fish, whereas 585 
high amounts of DMA in urine were linked to the ingestion of seaweed (Mohri et al., 1990). 586 
Previous studies have shown a range of metabolites in the urine of humans after ingestion of 587 
seaweed, mollusks or synthetic arsenosugar, with DMA being the major metabolite 588 
(Francesconi et al., 2002; Le et al., 1994; Ma and Le, 1998; Raml et al., 2009). The 589 
mechanism by which DMA is formed, and whether toxic intermediates, i.e. iAs or trivalent 590 
methylated species, are formed, is at present unknown. Francesconi et al. (2002) found that 591 
the proportion of DMA excreted by one volunteer after ingesting a synthetic arsenosugar was 592 
67 %. Eleven other As compounds, nine of them unidentified, were also excreted 593 
(Francesconi et al., 2002). Francesconi et al. also noted a delayed excretion of DMA, with a 594 
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peak at about 24 hours after intake of a synthetic arsenosugar. This is similar to our results 595 
with regard to the excretion pattern for DMA following intake of blue mussel (which contains 596 
arsenosugars). In a study in which two volunteers ingested cod liver oil (which contain 597 
arsenolipids) (Schmeisser et al., 2006), the main metabolite excreted in urine was also DMA. 598 
 599 
Consumption of seafood high in arsenolipids and/or arsenosugars, which are metabolized into 600 
DMA - the same main metabolite, which is formed from iAs - could, provided it is formed in 601 
a similar way, be an indication of health concern which should be further investigated. Most 602 
epidemiologic studies exploring seafood intake and impact on human health do not 603 
distinguish between different seafood and fish species and have not taken As in seafood into 604 
consideration.  605 
 606 
In the salmon and the blue mussel groups, approximately 40-50 % of non-AB As absorbed 607 
seemed to be excreted as DMA, while in the cod group, this fraction was only about 10 % 608 
(Table 4). In the cod group, much of the remaining non-AB As absorbed might have been 609 
metabolized into AB. Although the very good fit (R2=0.93) of the ANCOVA model it could 610 
be a modeling artifact. This does not seem very likely: Absorption was estimated from total 611 
As (tAs) excretion and AB intake was determined independently of urine analyses. 612 
Furthermore, DMA excretion was analyzed independently, and did not correlate strongly with 613 
tAs excretion. 614 
  615 
The sum of excreted arsenite, arsenate, MA and DMA have commonly been used as a 616 
biomarker for recent iAs exposure (Mandal and Suzuki, 2002; Steinmaus et al., 2009). This 617 
assumption does not take into account that preceding seafood intake may influence the DMA 618 
excretion, particularly intake of seafood that contains arsenosugars and/or arsenolipids. Our 619 
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results strongly support the notion that DMA excretion may poorly reflect iAs ingestion in 620 
subjects exposed to seafood arsenic. 621 
 622 
4.3. Possible iAs formation and MA excretion 623 
All groups excreted far less iAs than ingested, 22 %, 14 %, 14 % during day 0-2 in the cod, 624 
salmon and blue mussel groups, respectively. Nor did any individuals excrete more iAs than 625 
ingested, so no indications for formation of iAs in the body after seafood ingestion were 626 
obtained in the present study.  627 
 628 
Another finding, consistent with previous studies on seafood As exposure, was that all the 629 
groups excreted a small amount of MA, although the amount of dietary MA, which is largely 630 
excreted unchanged or as DMA, was below LOQ (Arbouine and Wilson, 1992; Buchet et al., 631 
1996; Buchet et al., 1994; Mohri et al., 1990). A lower degree of methylation, i.e. a higher 632 
amount of urinary MA, has in epidemiological studies been associated with increased health 633 
risk, as e.g. cancer in the lung. It is documented that the methylation capacity is less efficient 634 
in men than women (Vahter et al., 2007), but our data sample was too small to determine 635 
gender difference. As regards evaluation by reference to the relative amounts of As 636 
metabolites in urine, low MA in urine is thought to indicate a higher rate of iAs elimination 637 
(Buchet et al., 1994; Vahter, 2002). In the present study, the relative percentages of iAs, MA 638 
and DMA excreted by the seafood groups were 0.2 %–0.6 % (iAs), 0.7 %–2.3 % (MA) and 2 639 
%–31 % (DMA) (Table 3). These results are similar to the results of a comparable study in 640 
which volunteers ate different kinds of seafood, and in which the relative urinary As 641 
percentages were 0.04 %–0.94 % (iAs), 0 %–0.48 % (MA) and 1 %–22 % (DMA) (Buchet et 642 
al., 1994).  643 
 644 
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4.4. Strengths and weaknesses of the study 645 
The strength of this study is the study design with a controlled diet period with speciation of 646 
both dietary and urinary As, including full collection of three-day urine excretion after the 647 
bolus dose. The study design made it possible to shed light on several basic assumptions often 648 
made about As metabolism. Although some previous studies have provided data on both 649 
ingested and excreted As compounds (Buchet et al., 1996; Buchet et al., 1994; Mohri et al., 650 
1990), these studies had fewer subjects (between five and nine), and generated fewer 651 
speciation data related to the As compounds ingested. In addition, the present study controlled 652 
the As intake by including not only restrictions on seafood consumption, but also restrictions 653 
on other foodstuffs with a potential As content. 654 
  655 
One weakness of the study was that it included an unknown source of As on day 1 in the 656 
strictly controlled diet period, which was supposed to be As-free. The main As compound in 657 
this extra loading was AB, probably originating from the roasted chicken meal (Table 2). As 658 
it is prohibited to use As-containing feed additives in Europe, the As might originate from the 659 
use of fish meal in chicken fodder. Several diet studies have found poultry to be a major 660 
contributor to As intake (Dabeka et al., 1993; Lasky et al., 2004; Tao and Bolger, 1999).  661 
 662 
5. Main findings and Conclusion 663 
The first assumption, that absorption of AB is rapid and more or less complete, is refuted by 664 
our results. Our data show that there are large individual variations in the estimated 665 
absorption of AB, from around 50 to close to 100 %. 666 
 667 
The second assumption, that absorbed AB is excreted rapidly and unchanged mainly in urine, 668 
and that the process is basically independent of the dietary source of AB, is also questionable 669 
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in light of our results. AB in salmon was less well absorbed and apparently more slowly 670 
excreted than AB in cod.  671 
 672 
The third assumption, that there is no formation of AB in the body, is also cast into doubt by 673 
our results. The majority of the subjects in the blue mussel group apparently excreted far more 674 
AB than they had ingested, and overall AB excretion in both the blue mussel and the cod 675 
group was higher than expected from the estimated absorption. 676 
 677 
The fourth assumption, that DMA (and MA) mainly is produced by methylation of inorganic 678 
As, and that urinary DMA (or MA) therefore can be used as a marker of inorganic As load, is 679 
strongly contradicted by our results in all three seafood groups, but to least degree in the cod 680 
group. Our results show that a small portion of DMA excreted in seafood consumers comes 681 
from dietary iAs. Hence, the assumption that DMA can serve as a biomarker of iAs intake is 682 
only valid when iAs, e.g. from drinking water, is the dominating species ingested and other 683 
dietary sources are removed or taken into account. 684 
 685 
The last question we posed was if seafood consumption can increase the body load of iAs 686 
through metabolism of organoarsenicals. Provided that the formation of DMA from 687 
organoarsenicals does not take place via released iAs, our data do not indicate that 688 
organoarsenicals from seafood increases the load of iAs. 689 
 690 
It should, however, be noted that the high loads of As associated with a high fish/seafood 691 
intake, in particular from seaweed and mussels where iAs can be released, might be of some 692 
concern and should be further studied. Future research should also address the possible health 693 
impact of ingesting arsenosugar/arsenolipid containing seafood, due to the high excretion of 694 
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the main metabolite of inorganic As, DMA. Finally, the mechanism of how DMA is formed 695 
from these arsenicals and how AB can be formed by ingested organoarsenicals should be 696 
further explored.  697 
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Legends to figures: 837 
 838 
Figure 1 839 
Study design. The arrows pointing upwards indicate the time the urine and blood samples 840 
were collected. Regarding the urine samples, it is indicated whether the sample was a spot 841 
sample (spot) or part of a complete sampling (24h). 842 
 843 
Figure 2 844 
Time course of urinary tAs excretion and plasma tAs 0-72 hours after test meal.  845 
A: Group means of urine tAs excretion rate (µg /h).  846 
B: Group means of plasma tAs concentrations (µg/L) (Last measurement at 48h). Bars 847 
indicate standard deviation.  848 
C: Group means of cumulative urinary tAs excretion as fraction of total amount of tAs 849 
ingested. Excreted fraction of tAs ingested were significantly higher in the cod group than in 850 
the salmon (P<0.005) and blue mussels (P<0.0005) groups. The latter two groups did not 851 
differ significantly. 852 
D: Cumulative urinary tAs excretion as fraction of tAs ingested. Individual curves for the cod 853 
and salmon groups.  854 
 855 
Figure 3 856 
A: Group means of urine AB excretion rate (µg /h) after test meal 0-72h.  857 
B: Cumulative urinary AB excretion as percentage of AB ingested. Individual curves for the 858 
cod and salmon groups (actual data shown, no corrections or estimations). AB excretion as a 859 
fraction of AB ingested were significantly higher in the cod and blue mussels groups (see 860 
Table 4) (P<0.0001) than in the salmon and control groups.  861 
37 
 
C: Total excreted AB 0-72h (observed) as a percentage of estimated absorbed AB, plotted 862 
against estimated absorbed AB for each of the study groups. For each individual, AB 863 
absorption is assumed to be equal to total As (tAs) absorption, which is estimated as estimated 864 
total tAs excretion divided by tAs ingested. 865 
 866 
Figure 4 867 
A: Group means of urine DMA excretion rate (µg /h) after test meal.  868 
B: Cumulative urinary DMA excretion 0-72h as percentage of non-AB As (non-AB) ingested 869 
after test meal, individual curves for the cod and salmon groups (actual data shown, no 870 
corrections or estimations). 871 
C: Total excreted DMA 0-72h (observed) as a percentage of estimated absorbed non-AB As, 872 
plotted against estimated absorbed non-AB As for each of the study groups. The percentage 873 
of DMA excreted was significantly smaller (P<0.0001) for the cod group than for the salmon 874 
and blue mussels groups. The latter two groups did not differ significantly. For each 875 
individual, non-AB As absorption is assumed to be equal to total As (tAs) absorption, which 876 
is estimated as estimated total tAs excretion divided by tAs ingested. 877 
 878 
Table 1: Baseline characteristics and urinary total arsenic (tAs) concentrations of the study population (mean (± SD) and median 
(min-max)). 
 Total Cod Salmon Blue mussel Control 
Baseline characteristics      
Gender (male/female) 10/28 3/6 0/11 3/5 4/6 
Age (years) 25.4 (5.0) 
24 (20-40) 
23.2 (3.4) 
22 (20-31) 
25.0 (3.1) 
25 (21-32) 
27.9 (6.3) 
25.5 (22-37) 
25.9 (6.3) 
24.5 (20-40) 
BMI (kg/m2) 23.9 (3.3) 
23.4 (19.5-33.3) 
23.4 (2.4) 
23.3 (20.2-29.2) 
22.4 (1.9) 
22.5 (19.5-25.3) 
24.6 (4.3) 
23 (21.1-32.5) 
25.5 (3.8) 
24.3 (20.8-33.3) 
Urinary tAs 
concentrations 
     
Urinary tAs (μg/L)  
(day -7, baseline)  
83 (150) 
27 (5-910) 
72 (56) 
67 (7-188) 
149 (270) 
23 (7-910) 
75 (82) 
28 (19-209) 
27 (28) 
15.5 (5-90) 
Urinary tAs (μg/L) 
(day 0, study start)   
20 (15) 
16 (4-77) 
15 (7.8) 
14 (4-31) 
20 (12) 
16 (5-39) 
 
29 (24) 
19.5 (6-77) 
 
18 (13) 
17 (5-39) 
 
 
 
 
 
 
Table 2: The content of arsenic compounds in the test meals and in the duplicate portions of the strictly controlled diet (mean1). 
 
 Seafood meal Duplicate portions (72h)2 
 Cod Salmon Blue mussels Control All intervention groups 
tAs (µg) 670 180 620 3.7 110 
iAs (µg) 2.8 3.3 13.0 4.4 3.2 
DMA ( µg) 1.3 3.0 15.0 0.1 1.5 
MA < 0.15 <  0.15 < 0.15 < 0.15 < 0.15 
AB (µg) 490 140 160 0.8 76 
TMAO (µg) 3.0 6.0 4.4 < 0.5 < 0.5 
DMAE (µg) < 0.5 < 0.5 6.6 < 0.5 < 0.5 
TMAP (µg) 2.9 < 0.5 42 < 0.5 < 0.5 
TETRA (µg) 1.2 < 0.5 5.4 < 0.5 < 0.5 
AC (µg) 3.8 < 0.5 5.4 < 0.5 < 0.5 
Unknowns3 (µg) 170 28 368 0 29 
 
 
 
                                                 
1  The mean value was calculated for two identical samples of each of the test meals and the duplicate portions of the strictly controlled diet.  
2  Menu of the diet: day 0; seafood/control meal for breakfast, sandwich with ham and cheese for lunch and pasta with minced meat for dinner, day 1; 
Greek salad for lunch and roasted chicken with potato salad, day 2; ham and pasta salad for lunch and Greek meatballs with couscous for dinner. All other 
meals consisted of bread with cheese/meat/jam and orange/apple juice. 
3  Unidentified peaks in the chromatogram and unextracted arsenicals. 
 
Table 3 Ingestion1 of tAs, iAs, DMA, MA and AB and urinary excretion 72h following intake of the test meal (mean (± SD)).  
Group/ 
Species 
1i 
Amount 
ingested 
2 
Percentage of 
total As 
ingested 
 
 
 
3 
Urine day 0 
 
 
 
 
4 
Urine day 1 
 
 
 
 
5 
Urine day 2 
 
 
 
 
6ii 
Urine day 0-2 
 
 
 
 
7iii 
Urine day 0-2: 
% of the As 
species 
ingested 
excreted 
8iv 
Total excreted: 
estimated 
 
 
9v 
Total excreted: 
estimated % of 
As species 
ingested 
 µg % µg (SD) µg (SD) µg (SD) µg (SD) % (Range) µg (Range) % (Range) 
Cod group          
Total As  780 100 446 (90) 83 (21) 46 (13) 576 (94) 74 (52 - 92) 630 (447 - 769) 81 (58-99) 
 Inorganic As  6 0.8 0.4 (0.3) 0.5 (0.2) 0.5 (0.3) 1.3 (0.6) 22 (8 – 44)   
DMA  2.8 0.4 5.4 (1.1) 1.7 (0.5) 1 (0.3) 8 (1) 301 (204- 373)   
 MA  <0.15 0 1.9 (3.2) 0.5( 0.2) 1.5 (1.1) 3.9 (3.1) 0 (0-0)   
 AB  570 73 388 (71) 78 (19) 42 (12) 507 (73) 90 (64 - 105) 556 (409 - 640) 99 (72-113) 
Non-AB As 210 27 58 (41) 5(8) 5 (8) 68 (41) 32 (5-64) 74 (34-135) 35 (16-64) 
Salmon group          
 Total As  290 100 101 (24) 40 (11) 20 (7) 161 (30) 56 (46 - 82) 185 (141 - 267) 64 (49-93) 
Inorganic As  6.5 2.3 0.3 (0.1) 0.3( 0.1) 0.3 (0.1) 0.9( 0.3) 14 (8- 23)   
DMA  4.5 1.6 8.6 (1.7) 2.7 (0.3) 1 (0.4) 13 (2) 283 (232 - 355)   
MA  <0.15 0 1.2 (0.9) 2.1 (3.7) 0.4 (0.2) 3.7 (3.6) 0 (0-0)   
AB  220 76 70 (7) 36 (10) 15 (6) 121 (19) 56 (48 - 77) 139 (111 - 198) 64 (51-90) 
Non-AB As 70 24 31 (19) 4(2) 5(4) 40(21) 57 (34-141) 46 (25-107) 66 (36-155) 
Blue mussels group          
Total As  690 100 219 (38) 74 (11) 36 (8) 328 (47) 49 (37 - 78) 371 (297 - 449) 56 (41-86) 
Inorganic As  15 2.2 1.0 (0.9) 0.4 (0.1) 0.7 (1.1) 2.1 (1.6) 14 (5 - 30)   
DMA  16 2.3 46 (17.7) 17.2 (8.3) 7 (3.4) 71 (21) 451 (355 – 611)   
MA  <0.15 0 2.5 ( 0.9) 2.4 (1.8) 2.3 (2.0) 7.2 (2.7) 0 (0-0)   
AB  230 33 143 (27) 50 (6) 25 (9) 217 (30) 99 (82 - 151) 247 (200 - 313) 112 (87-173) 
Non-AB As 460 67 76 (17) 24 (10) 11 (10) 111 (29) 25 (14-35) 124 (71-184) 28 (14-37) 
Control group          
Total As  110 100 14 (6) 23 (7) 13 (3) 50 (12) 45 (30 – 60) 65 (44 - 84) 58 (39-75) 
Inorganic As  7.6 6.8 0.3 (0.1) 0.4( 0.3) 0.3 (0.1) 1.0 (0.4) 13 (6-20)   
DMA  1.6 1.4 4.3( 3.4) 2(1.9 ) 1 (0.6) 8 (5) 485 (266- 1185)   
MA  <0.15 0 1.0 (0.5) 1.4 (2.5) 0.7 (0.4) 3.1 (2.5) 0 (0-0)   
AB  77 70 6 (4) 20 ( 6) 9 (3) 36 (10) 46 (31 – 65) 46 (30 - 63) 60 (39-82) 
Non-AB As 33 30 8 (4) 3(3) 4 (1) 14 (7) 43 (24-100) 19 (13-40) 56 (39-119) 
 
                                                 
1 Ingested both from test meal on 0h and from the diet (measured from double-portions) 72h after the meal. Two participants in the blue mussel group did not 
eat all seafood in the meal; 100/150g and 125/150g. This is taken into account when presenting the data. 
 
 
i Column 1-5: Ingestion and urinary excretion 0-72h of tAs, iAs, DMA, MA and AB following intake of the test meal (mean (± SD)). 
ii Column 6: Total of As species excreted in urine day 0-2 (measured), mean and SD. 
iii Column 7: Column 6 as percentage of column 1, mean and range. 
ivColumn 8:  Estimated total of As species excreted after a bolus dose, column 6 plus estimated residual, mean and range.  
v Column 9:  Estimated total of As species excreted after a bolus dose, column 8, as percentage of species ingested, column 1, mean and range. For tAs, 
estimated amount excreted is also used as an estimate for amount absorbed, making the ratio of estimated amount tAs excreted to amount ingested an 
estimate of fraction of As absorbed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4 
Coefficients (SD in parentheses) of optimal ANCOVA regression models1 using common intercepts and different slopes, for (1) 0-
72h urinary excretion of arsenobetaine (AB) against estimated absorbed AB, and (2) urinary 0-72h excretion of dimethylarsinate 
(DMA) against estimated absorbed non-AB As. Coefficients with different superscripts are significantly different (p<0.05). In the 
model for AB, a coefficient above 1 indicates that AB may be formed in the body, as more AB is excreted than apparently absorbed.  
In the model for DMA, the coefficient indicates the tendency for non-AB As to be excreted as DMA (assuming no appreciable 
amount of dietary AB is excreted as DMA.) Thus, the three study groups differed significantly in 0-72h AB excretion relative to 
intake, the salmon group excreting less than absorbed, the cod group somewhat more, and the blue mussels group 1.62 times 
more than absorbed. For DMA, only 10% of absorbed non-AB As seemed to be excreted as DMA, significantly different from 43% in 
the blue mussels group. The coefficient was even higher (52%) in the salmon group, but the large SD rendered the differences to 
the other groups non-significant. 
 
 1 2 
 Arsenobetaine, 
(R²=0.99,SD=22.3) 
Dimethylarsinate, 
 (R²=0.93,SD=10.1) 
Intercept 43.13 (20.9) - 6.06 (9.63) 
Cod 1.10 (0.05)a    0.10 (0.06)a 
Salmon 0.68 (0.15)b     0.52 (0.22)ab 
Blue mussels 1.62 (0.18)c    0.43 (0.04)b 
Control 0.10 (0.47)ab     0.92 (0.49)ab 
 
 
 
                                                 
1Asexcr = b0 +b1i Asabsorbed, i=1,..,4 (i representing the different seafood/potato groups). 
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Merknad [m1]: Trond, vi må endre på 
teksten i figur 3B. Holder det å endre 
teksten til ”urinary arsenic excretion, % of 
AB ingested”? 
Figure 4 
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